Connect with us

Health

New Zealand reports first death linked to Pfizer/BioNTech COVID-19 vaccine – National Post

Published

 on


Article content

WELLINGTON — New Zealand reported its first recorded death linked to the Pfizer/BioNTech COVID-19 vaccine, the health ministry said on Monday, after a woman suffered a rare heart muscle inflammation side effect.

The report comes as the country battles an outbreak of the Delta variant of the coronavirus after nearly six months of being virus free. It followed a review by an independent panel monitoring the safety of the vaccines.

“This is the first case in New Zealand where a death in the days following vaccination has been linked to the Pfizer COVID-19 vaccine,” the ministry said in a statement, without giving the woman’s age.

Advertisement

Article content

The vaccine monitoring panel attributed the death to myocarditis, a rare, but known, side effect of the Pfizer vaccine, the ministry added.

The board said the myocarditis “was probably due to vaccination,” according to the ministry. The health ministry said other medical issues at the same time could have influenced the outcome after vaccination.

Myocarditis is an inflammation of the heart muscle that can limit the organ’s ability to pump blood and can cause changes in heartbeat rhythms.

Pfizer said it recognized there could be rare reports of myocarditis after vaccinations, but such side effects were extremely rare.

“Pfizer takes adverse events that are potentially associated with our vaccine very seriously,” the company said.

Advertisement

Article content

“The benefits of vaccination with the Pfizer COVID-19 vaccine continue to greatly outweigh the risk of both COVID-19 infection and vaccine side effects, including myocarditis,” Pfizer said.

Regulators in the United States, the European Union and the World Health Organization have said that mRNA vaccines from Pfizer with German partner BioNTech and by Moderna are associated with rare cases of myocarditis or pericarditis, an inflammation of the lining around the heart, but that the benefits of the shots outweigh any risks.

The cases, affecting mainly younger men, tend to be mild and treatable but can lead to serious illness and hospitalization.

There have been no U.S. deaths reported for young adults who developed myocarditis after being given the mRNA vaccines, the U.S. Centers for Disease Control and Prevention (CDC) said on Monday.

Advertisement

Article content

Separately, it also said that a total of 2,574 U.S. cases of myocarditis or pericarditis had been reported. More than 330 million doses of the Pfizer/BioNTech and Moderna vaccines have been administered in the United States.

The risk of myocarditis was 18.5 per million doses given among people aged 18 to 24 after their second Pfizer dose and 20.2 per million for that age group among Moderna second dose recipients. The risk decreases with age, according to the CDC analysis based on its national reporting system.

The EU’s drug regulator said on July 9 that five people had died due to the heart side effect after receiving either of the two mRNA vaccines in the European Economic Area, all of whom were elderly or had other diseases. More than 200 million mRNA doses have been administered in the region.

Advertisement

Article content

New Zealand has provisionally approved use of the Pfizer/BioNTech, Johnson & Johnson and AstraZeneca vaccines, but only the Pfizer vaccine has been approved for rollout to the public. More than 3 million doses have been given so far, mostly to people over 50.

New Zealand reported 53 new COVID-19 cases on Monday, taking its tally of infections in the current outbreak to 562, amid a nationwide lockdown enforced this month to limit spread of the Delta variant.

(Reporting by Praveen Menon Additional reporting by Ludwig Burger in Frankfurt and Caroline Humer in New York; Editing by Christian Schmollinger, Clarence Fernandez, Nick Macfie and Bill Berkrot)

Advertisement

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Adblock test (Why?)



Source link

Continue Reading

Health

More than half of Manitoba's 64 new COVID-19 cases unvaccinated – CTV News Winnipeg

Published

 on


WINNIPEG –

While more than half of Manitoba’s new COVID-19 cases are among the unvaccinated, the province reported 20 breakthrough infections.

On Thursday, Manitoba public health officials reported 64 new COVID-19 cases – including 36 unvaccinated cases and eight partially vaccinated cases. Twenty of the cases were among people who had been fully vaccinated.

“No vaccine is 100 per cent effective. However, people who are fully vaccinated typically have a better outcome than individuals who are not vaccinated,” a spokesperson told CTV News in an emailed statement.

“Public health continues to recommend that the best defence against COVID-19 is to get immunized.”

As of Thursday, 84 per cent of eligible Manitobans have rolled up their sleeve for at least one dose of a COVID-19 vaccine. Seventy-nine per cent of eligible Manitobans are vaccinated with two doses.

The spokesperson said while breakthrough cases can occur, the outcomes are typically not as severe as they are for non-vaccinated individuals. They said fully vaccinated people who get infected typically do not need to go to ICU.

As of Thursday, 62 people in Manitoba are in hospital with COVID-19, including 26 people who have active cases. Of those active cases, 20 are not vaccinated, four are partially vaccinated and two are fully vaccinated.

There are five people in the intensive care unit with active cases of COVID-19, all of whom are unvaccinated.

Data from the province obtained by CTV News shows there have been 728 infections and 16 deaths among the 915,200 people fully immunized in the province.

Of the 986,054 people who have been partially immunized in Manitoba, the data shows there have been 2,215 infections and 45 deaths.

The Southern Health region saw the most cases in the province on Thursday, with 23 new cases reported.

The Northern and Winnipeg health regions both reported 15 new cases. Winnipeg is sitting with a 1.2 per cent five-day test positivity rate.

The Prairie Mountain Health Region reported six new cases and the Interlake-Eastern health region reported five new cases.

The new cases bring Manitoba’s total to 59,526, including 599 active cases and 57,724 recoveries. Seven cases were removed from the total due to data corrections.

The provincial five-day test positivity rate is now 2.5 per cent.

The province also released some details of two deaths that were announced on Wednesday – both of which were linked to variants of concern. The deaths include a woman in her 70s from the Interlake-Eastern health region, linked to the Delta variant, and a man in his 80s from Winnipeg linked to an unspecified variant.

The total number of people who have died with COVID-19 sits at 1,203, including 201 deaths that have been linked to variants of concern.

In total, Manitoba has linked 18,065 cases to variants. 370 variant cases are active, and 17,494 have recovered.

Adblock test (Why?)



Source link

Continue Reading

Health

Goodbye Pfizer, hello Comirnaty: top COVID-19 vaccines renamed in Canada – KitchenerToday.com

Published

 on


It’s pronounced koh-MIHR’-nuh-tee. Never heard of it? Well, get used to it. It’s what Canada will be calling the Pfizer vaccine from now on, at least officially.

Health Canada has approved new monikers for Pfizer, Moderna and Oxford-AstraZeneca vaccines and announced the change on social media today.

The Pfizer-BioNTech vaccine has now been dubbed Comirnaty, which the company says represents a combination of the terms COVID-19, mRNA, community, and immunity.

The Moderna vaccine will go by SpikeVax and the AstraZeneca vaccine will be named Vaxzevria.

Pfizer and Moderna say the change marks the full approval of the vaccines by Health Canada, which were previously approved under an interim order that was set to expire today.

During the interim order, the vaccines didn’t go by their brand names, but now that new and more long-term data has been submitted and approved they will go by their permanent name.

“Health Canada’s approval of COMIRNATY for individuals ages 12 and older affirms the vaccine’s safety and efficacy shown in longer term data submitted to Health Canada — and hopefully that licensure may improve vaccine confidence among Canadians,” Pfizer spokesperson Christina Antoniou wrote in a statement.

It’s the first time SpikeVax, until now known as the Moderna vaccine, has been fully approved anywhere in the world, Stéphane Bancel, the company’s CEO, said in a press release Thursday.

Health Canada points out the vaccines themselves are not changing — only the names are.

Although the name change has been approved, Canada will still receive vials labelled Pfizier-BioNTech for the next several months.

The FDA approved new names in the United States earlier this summer, and the vaccines have been going by their brand names in the EU since the spring.

Story by Laura Osman, The Canadian Press

Adblock test (Why?)



Source link

Continue Reading

Health

How concerning is the latest COVID-19 Mu variant in B.C.? – News 1130

Published

 on


VANCOUVER (NEWS 1130) — A new strain of the COVID-19 virus is now in the province, and it is leading to questions around potential risk.

The B.1.621 — or Mu — variant was first discovered in Colombia in January and has been found in more than 40 people in B.C. since June. The World Health Organization has now classified the strain as a “Variant of Interest.”

The case numbers are minimal compared to the highly transmissive Delta variant, which has exploded across the country, leading to more COVID-19 cases and hospitalizations.

Related Video:

In B.C. alone, nearly all the new cases of COVID-19 are linked to the Delta variant.

Still, there was a time when the impact of that strain was not known, prompting many to worry that the new Mu variant could be just as dangerous as Delta.

Sally Otto, a UBC zoology professor and modelling researcher, says right now, that’s not the case and there is no need to panic.

“Mu hasn’t actually been rising in frequency, it’s been kind of hovering under about two per cent frequency, relative to what we saw with Delta, which was once it got established, [there was] really rapid exponential growth,” Otto said.

“That doesn’t mean we shouldn’t pay attention to it, we absolutely should keep an eye on it. But it’s not taking off. Right now, Delta is the main player, the main variant that is the most transmissible and the most worrisome in this country,” Otto said.

Dr. Birinder Narang, co-founder of This is Our Shot campaign, agrees. “It is not showing a significant impact in B.C., we need to watch,” he wrote on social media.

The bigger concern than the variant itself, Otto says, is how slow Canada is at sharing data from mapping virus sequences to discover variants of interest present in the population.

A new report found Canada among the worst for sharing data on genome sequencing.

Canada takes three months to present collected data to the global database, compared to the United Kingdom which is able to do it in just two weeks.

Related Article:

The data is then studied by public health officials, scientists, and other experts around the world to examine what variants are present, and how fast they are spreading.

“There could absolutely be more variants. Now to be honest, Canada doesn’t have as much cases as there are globally so the chances are the variant of concern is going to arise somewhere else. But if a variant of concern arises in Canada, we can’t tell.”

She says the delay in information impacts making real-time decisions on public policy surrounding the virus.

“We can’t tell within Canada if there are subtypes of the Delta that are spreading faster than others, and that’s something we need to know,” she said about the mutations and which ones to pay attention to.

Otto says the disconnect of information sharing is even happening in Canada between provinces and territories.

“Here in British Columbia we are sequencing almost every single case of COVID to try and identify what exactly the genetic changes are inside the genome of the virus. But unfortunately that is not then being shared globally, and it’s not even being shared across Canada. And that means that scientists like me who aren’t inside the public health office, we can’t use our skills to look for the changes that are happening in these genomes,” she said, adding the last time B.C. updated their data was two months ago.

Despite fears, the BC Centre of Disease Control says the current vaccines protect against all variants of concern, including Delta, and because variants spread more easily, it is even more important for the majority of the population to be vaccinated.

“This helps protect people who cannot get vaccinated, including children under 12,” the BCCDC explained.

With files from Nikitha Martin

Adblock test (Why?)



Source link

Continue Reading

Trending